Skip to main content
Premium Trial:

Request an Annual Quote

Percentage Change in Stock Valuation in 6-Month Period Ended March 8, 2005








Harvard Bio’s Weekly Stock Performance Since April 10, 2003.*
9/8/2004
3/8/2005
Pct. Change
Molecular Devices
24.18
20.05
-17.08
Bio-Rad
51.62
48.51
-6.02
Harvard Bio
4.71
4.43
-5.94
Thermo
26.59
27.69
4.14
Strategene
7.09
7.39
4.23
GE
33.66
36.06
7.13
Applied Biosystems
18.83
20.69
9.88
Waters
44.56
49.32
10.68
Sigma
56.51
63.79
12.88
Bruker
3.3
3.78
14.55
BD
50.62
58.85
16.26
Beckman
58.18
69.88
20.11
Agilent
20.18
24.36
20.71
PerkinElmer
17.38
23.01
32.39
Invitrogen
48.87
71.66
46.63
Total
31.09
35.30
13.55

File Attachments
The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.